SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4kaq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_A_CLMA1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
5 / 7 GLY H  54
PRO H  53
THR H  58
ILE H  51
GLY H  56
None
1.06A 1usqA-4kaqH:
undetectable
1usqA-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_B_CLMB1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.74A 1usqB-4kaqH:
undetectable
1usqB-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_C_CLMC1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.73A 1usqC-4kaqH:
undetectable
1usqC-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_D_CLMD1142_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.74A 1usqD-4kaqH:
undetectable
1usqD-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1USQ_E_CLME1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.74A 1usqE-4kaqH:
undetectable
1usqE-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_A_CLMA1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.82A 2jkjA-4kaqH:
undetectable
2jkjA-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_B_CLMB1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.82A 2jkjB-4kaqH:
undetectable
2jkjB-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKJ_C_CLMC1141_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.82A 2jkjC-4kaqH:
undetectable
2jkjC-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_A_CLMA1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
5 / 7 GLY H  54
PRO H  53
THR H  58
ILE H  51
GLY H  56
None
1.08A 2jklA-4kaqH:
undetectable
2jklA-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_B_CLMB1144_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  54
PRO H  53
ILE H  51
GLY H  56
None
0.80A 2jklB-4kaqH:
undetectable
2jklB-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_C_CLMC1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
5 / 7 GLY H  54
PRO H  53
THR H  58
ILE H  51
GLY H  56
None
1.09A 2jklC-4kaqH:
1.4
2jklC-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_D_CLMD1145_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
5 / 7 GLY H  54
PRO H  53
THR H  58
ILE H  51
GLY H  56
None
1.08A 2jklD-4kaqH:
undetectable
2jklD-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JKL_F_CLMF1143_0
(DR HEMAGGLUTININ
STRUCTURAL SUBUNIT)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
5 / 7 GLY H  54
PRO H  53
THR H  58
ILE H  51
GLY H  56
None
1.08A 2jklF-4kaqH:
undetectable
2jklF-4kaqH:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JX1_B_CAMB502_0
(CAMPHOR
5-MONOOXYGENASE)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
5 / 10 PHE H 130
GLY H 126
THR H 213
VAL H 206
VAL H 215
None
1.16A 4jx1B-4kaqH:
undetectable
4jx1B-4kaqH:
17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOE_F_TR6F101_1
(DNA TOPOISOMERASE 4
SUBUNIT A
DNA TOPOISOMERASE 4
SUBUNIT B
E-SITE DNA2)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 SER H  99
GLY H  56
ASP H  57
GLY H  54
None
0.98A 4koeA-4kaqH:
2.4
4koeB-4kaqH:
2.4
4koeC-4kaqH:
undetectable
4koeA-4kaqH:
16.84
4koeB-4kaqH:
16.84
4koeC-4kaqH:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z53_F_TR6F101_1
(DNA TOPOISOMERASE 4
SUBUNIT B,DNA
TOPOISOMERASE 4
SUBUNIT A
E-SITE DNA)
4kaq RITUXIMAB HEAVY
CHAIN

(Homo
sapiens;
Mus
musculus)
4 / 6 GLY H  56
ASP H  57
GLY H  54
SER H  99
None
1.03A 4z53A-4kaqH:
2.0
4z53B-4kaqH:
2.3
4z53A-4kaqH:
13.74
4z53B-4kaqH:
13.74